Two-dimensional materials in biomedical, biosensing and sensing applications N Rohaizad, CC Mayorga-Martinez, M Fojtů, NM Latiff, M Pumera Chemical Society Reviews 50 (1), 619-657, 2021 | 356 | 2021 |
Environmental impact and potential health risks of 2D nanomaterials M Fojtů, WZ Teo, M Pumera Environmental Science: Nano 4 (8), 1617-1633, 2017 | 97 | 2017 |
Unexpected therapeutic effects of cisplatin M Raudenska, J Balvan, M Fojtu, J Gumulec, M Masarik Metallomics 11 (7), 1182-1199, 2019 | 92 | 2019 |
Black phosphorus nanoparticles potentiate the anticancer effect of oxaliplatin in ovarian cancer cell line M Fojtů, X Chia, Z Sofer, M Masařík, M Pumera Advanced Functional Materials 27 (36), 1701955, 2017 | 63 | 2017 |
Graphene oxide nanoplatelets potentiate anticancer effect of cisplatin in human lung cancer cells NF Rosli, M Fojtů, AC Fisher, M Pumera Langmuir 35 (8), 3176-3182, 2019 | 59 | 2019 |
Reduction of doxorubicin-induced cardiotoxicity using nanocarriers: a review M Fojtu, J Gumulec, T Stracina, M Raudenska, A Skotakova, ... Current drug metabolism 18 (3), 237-263, 2017 | 51 | 2017 |
Modulation of induced cytotoxicity of doxorubicin by using apoferritin and liposomal cages J Gumulec, M Fojtu, M Raudenska, M Sztalmachova, A Skotakova, ... International Journal of Molecular Sciences 15 (12), 22960-22977, 2014 | 48 | 2014 |
Sulforaphane-induced apoptosis involves the type 1 IP3 receptor S Hudecova, J Markova, V Simko, L Csaderova, T Stracina, M Sirova, ... Oncotarget 7 (38), 61403, 2016 | 31 | 2016 |
Pollen‐Based Magnetic Microrobots are Mediated by Electrostatic Forces to Attract, Manipulate, and Kill Cancer Cells CC Mayorga‐Martinez, M Fojtů, J Vyskočil, NJ Cho, M Pumera Advanced Functional Materials 32 (46), 2207272, 2022 | 30 | 2022 |
Engine shutdown: migrastatic strategies and prevention of metastases M Raudenská, K Petrláková, T Juriňáková, JL Fialová, M Fojtů, M Jakubek, ... Trends in Cancer 9 (4), 293-308, 2023 | 26 | 2023 |
Prognostic significance of the tumour-adjacent tissue in head and neck cancers M Raudenska, M Sztalmachova, J Gumulec, M Fojtu, H Polanska, ... Tumor Biology 36, 9929-9939, 2015 | 26 | 2015 |
Oxidized polysaccharides for anticancer-drug delivery: What is the role of structure? L Münster, M Fojtů, Z Capáková, M Muchová, L Musilová, T Vaculovič, ... Carbohydrate Polymers 257, 117562, 2021 | 25 | 2021 |
Black phosphorus cytotoxicity assessments pitfalls: advantages and disadvantages of metabolic and morphological assays M Fojtů, J Balvan, M Raudenská, T Vičar, D Bouša, Z Sofer, M Masařík, ... Chemistry–A European Journal 25 (1), 349-360, 2019 | 24 | 2019 |
Selectively oxidized cellulose with adjustable molecular weight for controlled release of platinum anticancer drugs L Münster, M Fojtů, Z Capáková, T Vaculovič, M Tvrdoňová, ... Biomacromolecules 20 (4), 1623-1634, 2019 | 22 | 2019 |
Locked and Loaded: Ruthenium(II)-Capped Cucurbit[n]uril-Based Rotaxanes with Antimetastatic Properties M Sojka, M Fojtu, J Fialova, M Masarik, M Necas, R Marek Inorganic Chemistry 58 (16), 10861-10870, 2019 | 21 | 2019 |
Evaluation of EGFR as a prognostic and diagnostic marker for head and neck squamous cell carcinoma patients H Polanska, M Raudenska, K Hudcová, J Gumulec, M Svobodova, ... Oncology letters 12 (3), 2127-2132, 2016 | 17 | 2016 |
Different doxorubicin formulations affect plasma 4-hydroxy-2-nonenal and gene expression of aldehyde dehydrogenase 3A1 and thioredoxin reductase 2 in rat M Hlavacova, J Gumulec, T Stracina, M Fojtu, M Raudenská, M Masarik, ... Physiological Research 64, S653, 2015 | 14 | 2015 |
Establishment of oral squamous cell carcinoma cell line and magnetic bead-based isolation and characterization of its CD90/CD44 subpopulations M Svobodova, M Raudenska, J Gumulec, J Balvan, M Fojtu, ... Oncotarget 8 (39), 66254, 2017 | 12 | 2017 |
2d germanane derivative as a vector for overcoming doxorubicin resistance in cancer cells M Fojtů, J Balvan, M Raudenská, T Vičar, J Šturala, Z Sofer, J Luxa, ... Applied Materials Today 20, 100697, 2020 | 11 | 2020 |
Effect of HPV on tumor expression levels of the most commonly used markers in HNSCC H Polanska, Z Heger, J Gumulec, M Raudenska, M Svobodova, J Balvan, ... Tumor biology 37, 7193-7201, 2016 | 10 | 2016 |